National Trends in Pediatric Admissions for Diabetic Ketoacidosis, 2006-2016

Estelle M Everett1,2,3, Timothy P Copeland4, Tannaz Moin1,2,5

  • 1Division of Endocrinology, Diabetes, & Metabolism, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, California, USA.

Insights

Diabetic ketoacidosis (DKA) admissions in children and young adults are increasing nationally. Vulnerable subgroups, including young females and Black youth, face the highest risks, necessitating targeted interventions.

Area of Science:

  • Pediatric Endocrinology
  • Public Health
  • Health Services Research

Background:

  • Diabetic ketoacidosis (DKA) incidence is rising in the United States.
  • Previous research indicated higher DKA rates in younger populations.
  • National trends and subgroup disparities in pediatric DKA have not been thoroughly examined.

Purpose of the Study:

  • To analyze national trends in pediatric diabetic ketoacidosis (DKA) admissions.
  • To investigate DKA rate differences across demographic subgroups over time.
  • To assess associated healthcare costs and length of stay for pediatric DKA hospitalizations.

Main Methods:

  • Utilized the Kids' Inpatient Database (2006-2016) for a nationally representative sample of pediatric admissions (≤20 years old).
  • Estimated DKA admission rates per 10,000 admissions and population, charges, and length of stay (LOS).
  • Employed regression models to evaluate temporal trends in DKA rates within demographic subgroups.

Main Results:

  • DKA admissions increased by approximately 40% from 2006 to 2016.
  • Mean charges per admission rose, while mean LOS slightly decreased.
  • Elevated DKA rates were observed in 18- to 20-year-old females, Black youth, uninsured individuals, and those from nonurban areas.

Conclusions:

  • Pediatric DKA admissions have significantly increased, with persistent disparities in vulnerable populations.
  • Young adults, males, uninsured individuals, and those from nonurban areas experienced greater increases in DKA rates.
  • Further research is needed to understand the challenges faced by high-risk groups and to develop targeted interventions.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
53
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.3K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.7K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
84
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
53
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.4K